New NIST Reference Material to Strengthen Quality Control for Biological Drugs
Source:
nistHealth
July 31, 2025 · 05:00
From the publisher
Impurities in these drugs can cause undesirable immune responses in patients and can significantly drive up costs for drug manufacturers.
The original article opens on the publisher's website.
More from General
View topic →Situational Awareness builds relationships with new brokers as it attempts rebound
financialTimes
Sep 11, 2026 · 10:15
The legal drama of imprisoned Sam Bankman-Fried is waiting on its last act
coinDesk
Sep 11, 2026 · 10:12
Election officials ban certain public workers from trading on prediction markets ahead of midterms
cnbc
Sep 11, 2026 · 10:00
Is Bessent winning the wrong battle in markets?
financialTimes
Sep 11, 2026 · 10:00
In pictures: The U.S. commemorates the 25th anniversary of 9/11
cnbc
Sep 11, 2026 · 09:50